• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 4, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Christof Niehrs of IMB elected as a member of the American Academy of Arts and Sciences

Bioengineer by Bioengineer
April 28, 2016
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Academy convenes leaders from the academic, business, and government sectors to address key challenges faced by today's global society. Through studies, publications, and programmes on various areas of the Arts and Sciences, the Academy provides authoritative and nonpartisan policy advice to decision-makers in government, academia, and the private sector. It currently has 4,600 Fellows and 600 Foreign Honorary Members. These include many of the most accomplished scholars and practitioners worldwide. Notable past Foreign Honorary Members of the society include Alexander von Humboldt, Charles Darwin, and Werner Heisenberg.

"I am honoured to have been elected to join such an exceptional group of scholars", says Christof Niehrs, "and I am very much looking forward to participating in the Academy's activities." Professor Niehrs is the Founding and Scientific Director of the Institute of Molecular Biology (IMB), which opened on the campus of Johannes Gutenberg University Mainz (JGU), Germany, in 2011. He is a developmental biologist who has received a number of honours and awards for his pioneering research into mechanisms underlying early embryonic development. His current research focusses on two fields, epigenetics of DNA methylation and Wnt growth factor signalling, both aiming to unravel how cells regulate differentiation and avoid disease.

Christof Niehrs is among 213 respected artists and scientists who have been elected to membership of the American Academy this year and one of the 37 Foreign Honorary Members. Other members of the 2016 class include winners of the Pulitzer Prize and the Wolf Prize, MacArthur and Guggenheim Fellowships, the Fields Medal as well as the Grammy and National Book Awards.

"It is an honour to welcome this new class of exceptional women and men as part of our distinguished membership," said Don Randel, Chair of the Academy's Board of Directors, in a press release. "Their election affords us an invaluable opportunity to bring their expertise and knowledge to bear on some of the most significant challenges of our day. We look forward to engaging these new members in the work of the Academy."

The new members of the Academy will be inducted at a ceremony on Oct. 08, 2016 at its headquarters in Cambridge, Massachusetts, USA.

###

Further information about Christof Niehrs' research can be found at http://www.imb.de/niehrs.

About the Institute of Molecular Biology gGmbH

The Institute of Molecular Biology gGmbH (IMB) is a centre of excellence in the life sciences that was established in 2011 on the campus of Johannes Gutenberg University Mainz (JGU). Research at IMB concentrates on three cutting-edge areas: epigenetics, developmental biology, and genome stability. The institute is a prime example of a successful collaboration between public authorities and a private foundation. The Boehringer Ingelheim Foundation has dedicated 100 million euros for a period of ten years to cover the operating costs for research at IMB, while the state of Rhineland-Palatinate provided approximately 50 million euros for the construction of a state-of-the-art building. For more information about IMB, please visit http://www.imb.de.

About the Boehringer Ingelheim Foundation

The Boehringer Ingelheim Foundation is an independent, non-profit organisation committed to the promotion of the medical, biological, chemical and pharmaceutical sciences. It was established in 1977 by Hubertus Liebrecht (1931-1991), a member of the shareholder family of the company Boehringer Ingelheim. With the PLUS 3 Perspectives Programme and the Exploration Grants, the foundation supports independent group leaders. It also endows the internationally renowned Heinrich Wieland Prize as well as awards for up-and-coming scientists. In addition, the foundation pledged to donate 100 million euros to finance the scientific running of the IMB at Johannes Gutenberg University Mainz for ten years. In 2013, the Boehringer Ingelheim Foundation donated a further 50 million euros to Johannes Gutenberg University Mainz. http://www.boehringer-ingelheim-stiftung.de.

Media Contact

Dr. Ralf Dahm
[email protected]
49-613-139-21455
@uni_mainz_eng

Startseite der JGU

The post Christof Niehrs of IMB elected as a member of the American Academy of Arts and Sciences appeared first on Scienmag.

Share12Tweet8Share2ShareShareShare2

Related Posts

Root Canal Bacteria and Breast Cancer: New Meta-Analysis Finds No Clear Link, But Clues to Tumor Progression

Root Canal Bacteria and Breast Cancer: New Meta-Analysis Finds No Clear Link, But Clues to Tumor Progression

October 4, 2026
AI Plans Safer Needle Paths for Lung Biopsies, Feasibility Study Finds

AI Plans Safer Needle Paths for Lung Biopsies, Feasibility Study Finds

October 4, 2026

Five Faces of Fear: How Cancer Patients Cope When War Comes to the Hospital Door

October 4, 2026

Immunotherapy Breakthroughs and Single-Cell Atlas Studies Reshape Liver Cancer Care in China

October 4, 2026
Please login to join discussion

POPULAR NEWS

  • Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

    29 shares
    Share 12 Tweet 7
  • Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

    29 shares
    Share 12 Tweet 7
  • Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

    29 shares
    Share 12 Tweet 7
  • New Scale Measures How Ready Nurse Educators Really Are for the AI Era

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Alloys That Shrink Their Own Grains: New PIX Mechanism Refines Metals With Heat Alone

Endurance Exercise Reshapes the Liver in Males and Females Through Distinct Molecular Routes

Single Transcription Factor PU.1 Rapidly Converts Fibroblasts into Macrophage-Lineage Cells

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.